摘要:目的:探討經(jīng)尿道前列腺等離子切除術(shù)(PKRP)治療前列腺增生癥(BPH)的療效及安全性。方法:回顧分析采用PKRP治療的BPH患者,收集患者臨床資料,隨訪12個月,并對手術(shù)前后患者國際前列腺癥狀評分、最大尿流率、生活質(zhì)量評分進行比較。結(jié)果:2006年8月至2008年8月PKRP手術(shù)治療BPH患者共238例,手術(shù)時間30～159 min,平均70 min,切除腺體25～127 g,平均54 g。無電切綜合征。術(shù)后及1年后最大尿流率、國際前列腺癥狀評分、生活質(zhì)量評分三項指標(biāo)較術(shù)前明顯改善(Plt;0.05)。結(jié)論:PKRP是治療BPH安全有效的治療方式。Abstract: Objective: To assess the clinical efficacy and safety of plasmakinetic energy transurethral resection of the prostate (PKRP) for benign prostatic hypertrophy (BPH). Methods: The data of patients with BPH treated with PKRP were retrospectively analyzed and the International Prostate Symptoms Scales (IPSS), maximum flow rate (Qmax) and Quality of Life (QOL) of patients with 12month followup were compared before and afteroperation and postoperation. Results: A total of 238 patients with BPH were enrolled from June 2006 to June 2008. The duration of the procedure was 70. 3 min (ranged from 30 min to 159 min) and the weight of dissected tissue was 54 g (ranged from 25 g to 127 g). No transurethral resection syndrome occurred. IPSS, Qmax and QOL were improved obviously after operation (Plt;0.05). Conclusion: PKRP is effective and safe.